Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Cancer Med. 2023 Jun;12(12):13054-13062. doi: 10.1002/cam4.5982. Epub 2023 Apr 21.
The risk and beneficial factors of early discharge after thoracoscopic anatomic lung cancer surgery are unknown, and this study aims to investigate predictors and associated 30-day readmission for early discharge.
We performed a single-center retrospective analysis of 10,834 consecutive patients who underwent thoracoscopic anatomic lung cancer surgery. Two groups were determined based on discharge date: "discharged by postoperative Day 2" and "discharged after postoperative Day 2." Univariable and multivariable analysis were conducted to identify predictors for discharge. Using propensity score matching (PSM) to compare 30-day readmission rate between two cohorts.
A total of 1911 patients were discharged by postoperative Day 2. Multivariable analysis identified older age (odds ratio (OR) = 1.014, p < 0.001), male sex (OR = 1.183, p = 0.003), larger tumor size (OR = 1.248, p < 0.001), pleural adhesions (OR = 1.638, p = 0.043), lymph nodes calcification (OR = 1.443, p = 0.009), advanced clinical T stage (vs. T < 2, OR = 1.470, p = 0.010), lobectomy resection (vs. segmentectomy resection, OR = 2.145, p < 0.001) and prolonged operative time (OR = 1.011, p < 0.001) as independent risk factors for discharge after postoperative Day 2. Three adjustable variables including higher FEV /FVC (OR = 0.989, p = 0.001), general anesthesia (GA) plus thoracic paravertebral blockade (vs. GA alone, OR = 0.823, p = 0.006) and uni-portal thoracoscopic surgery (vs. multi-portal, OR = 0.349, p < 0.001) were associated with a decreased likelihood of discharge after postoperative Day 2. Before and after a 1:1 PSM, discharged by postoperative Day 2 did not increase the risk of 30-day readmission compared to counterparts.
Carefully selected patients can be safely discharged within 2 days after thoracoscopic anatomic lung cancer surgery. Three modifiable variables may be favorable for promoting discharge by postoperative Day 2.
胸腔镜解剖性肺癌手术后早期出院的风险和有益因素尚不清楚,本研究旨在探讨预测因素和相关的 30 天内再入院率。
我们对 10834 例连续接受胸腔镜解剖性肺癌手术的患者进行了单中心回顾性分析。根据出院日期将两组分为“术后第 2 天出院”和“术后第 2 天以后出院”。采用单变量和多变量分析确定出院的预测因素。使用倾向评分匹配(PSM)比较两组 30 天内再入院率。
共有 1911 例患者在术后第 2 天出院。多变量分析确定年龄较大(优势比(OR)=1.014,p<0.001)、男性(OR=1.183,p=0.003)、肿瘤较大(OR=1.248,p<0.001)、胸膜粘连(OR=1.638,p=0.043)、淋巴结钙化(OR=1.443,p=0.009)、临床 T 分期较晚(T<2 期,OR=1.470,p=0.010)、肺叶切除术(与肺段切除术相比,OR=2.145,p<0.001)和手术时间延长(OR=1.011,p<0.001)是术后第 2 天出院的独立危险因素。三个可调整变量包括较高的 FEV/FVC(OR=0.989,p=0.001)、全身麻醉(GA)加胸段椎旁阻滞(与 GA 相比,OR=0.823,p=0.006)和单孔胸腔镜手术(与多孔相比,OR=0.349,p<0.001)与术后第 2 天出院的可能性降低相关。在 1:1 PSM 前后,与对照组相比,术后第 2 天出院并没有增加 30 天内再入院的风险。
精心选择的患者可以在胸腔镜解剖性肺癌手术后 2 天内安全出院。三个可调整的变量可能有利于促进术后第 2 天出院。